title: [Septicemias after endoscopic retrograde cholangiopancreatography. Risk factors and antibiotic prophylaxis].
abstract: The infection following endoscopic retrograde cholangiopancreatography (ERCP) is one of the most severe complications. The aim of the present study was to assess the prevalence and the prognosis of this complication, to look for the risk factors and to define bacterial ecology in order to put forward the most appropriate antibiotherapy. Two thousand and ten patients were included in this study. Among these, 51 (2.5%) had a septic complication following ERCP. Endoscopy biliary drainage was complete in 24 cases, incomplete in 19 and lacking in 8. Transhepatic biliary drainage was carried out in 17 cases. Sixteen patients (31%) with tumor obstructions died within 30 days after ERCP. Four risk factors were isolated when comparing infected patients with other patients: the completeness of biliary obstruction (90 vs 48%, P < 0.001); multiple cannulation attempts (1.76 +/- 1.12 vs 1.25 +/- 0.70, P < 0.001); the malignant nature of the obstruction (80 vs 23%, P < 0.002) and the lack of satisfactory drainage following endoscopy (53 vs 23%, P = 0.009). Pseudomonas aeruginosa was the most frequently isolated species, both from blood cultures (30%) and bile samples (23%). The preventive therapy of septic complications following ERCP must include strict rules concerning the disinfection of endoscopic material.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Service des Maladies du Foie et de l'Appareil Digestif, Universitaire de Bicêtre, Le Kremlin-Bicêtre.
authors.forename: P
authors.initials: P
authors.lastname: Novello
authors.forename: H
authors.initials: H
authors.lastname: Hagège
authors.forename: M
authors.initials: M
authors.lastname: Ducreux
authors.forename: C
authors.initials: C
authors.lastname: Buffet
authors.forename: A
authors.initials: A
authors.lastname: Choury
authors.forename: J
authors.initials: J
authors.lastname: Fritsch
authors.forename: C
authors.initials: C
authors.lastname: Liguory
authors.forename: L
authors.initials: L
authors.lastname: Jacques
authors.forename: J P
authors.initials: JP
authors.lastname: Etienne
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents; D016470:Bacteremia / Q000453:epidemiology* / Q000209:etiology / Q000382:microbiology / Q000517:prevention & control; D001646:Bile / Q000382:microbiology; D001660:Biliary Tract Diseases / Q000000981:diagnostic imaging* / Q000601:surgery; D001661:Biliary Tract Neoplasms / Q000000981:diagnostic imaging* / Q000601:surgery; D002760:Cholangiopancreatography, Endoscopic Retrograde / Q000009:adverse effects*; D004322:Drainage; D004359:Drug Therapy, Combination / Q000627:therapeutic use*; D005260:Female; D016905:Gram-Negative Bacterial Infections / Q000453:epidemiology / Q000209:etiology / Q000382:microbiology / Q000517:prevention & control; D016908:Gram-Positive Bacterial Infections / Q000453:epidemiology / Q000209:etiology / Q000382:microbiology / Q000517:prevention & control; D006801:Humans; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D012307:Risk Factors
chemical_list: D000900:Anti-Bacterial Agents
vernacular_title: Scepticémies après cholangiopancréatographie rétrograde endoscopique. Facteurs de risque et antibioprophylaxie.